These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18349742

  • 21. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M.
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [Abstract] [Full Text] [Related]

  • 22. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR, Gilliland WR, Miller RS, Decker CF.
    Scand J Infect Dis; 2009 Jun; 41(4):252-5. PubMed ID: 19266397
    [Abstract] [Full Text] [Related]

  • 23. Safety of conventional drugs and biologic agents for Rheumatoid Arthritis.
    Amoroso A, Gigante A, Gianni C, Amoroso D, Zennaro D, Galluzzo S, Caccavo D.
    Eur Rev Med Pharmacol Sci; 2003 Jun; 7(5):139-45. PubMed ID: 15214589
    [Abstract] [Full Text] [Related]

  • 24. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.
    Calabrese LH, Zein N, Vassilopoulos D.
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii18-ii24. PubMed ID: 15479865
    [Abstract] [Full Text] [Related]

  • 25. Minimizing infliximab toxicity in the treatment of inflammatory bowel disease.
    Orlando A, Mocciaro F, Civitavecchia G, Scimeca D, Cottone M.
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S236-46. PubMed ID: 18598995
    [Abstract] [Full Text] [Related]

  • 26. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J, Wu JJ, Dann FJ.
    Dermatol Ther; 2009 Jul; 22(1):61-73. PubMed ID: 19222518
    [Abstract] [Full Text] [Related]

  • 27. [Malignancy risk during TNF-blocking therapy increased or not?].
    Nurmohamed MT.
    Ned Tijdschr Geneeskd; 2012 Jul; 156(21):A4812. PubMed ID: 22617075
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
    Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Gonzalez-Juanatey C, de Matias JM, Martin J, Dessein PH, Llorca J.
    Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515
    [No Abstract] [Full Text] [Related]

  • 30. [Infectious risk].
    Calabuig E, Salavert M.
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [Abstract] [Full Text] [Related]

  • 31. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combination immunosuppressive therapies: the promise and the peril.
    Robinson MR, Korman BD, Korman NJ.
    Arch Dermatol; 2007 Aug; 143(8):1053-7. PubMed ID: 17709665
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.